Search Share Prices
AZN Headlines - AstraZeneca share price rises after upbeat trial results for diabetes drug
Shares in AstraZeneca (LON:AZN) have climbed higher in London in today’s session following upbeat trial results for its diabetes treatment Farxiga, and as the company said that one of its ...
Analyst at Deutsche Bank Reiterates AstraZeneca PLC (LON:AZN)Stock Rating as a ‘Buy’
Among 13 analysts covering AstraZeneca PLC (LON:AZN), 8 have Buy rating, 0 Sell and 5 Hold. Therefore 62% are positive. AstraZeneca PLC has GBX 6600 highest and GBX 62 lowest target. GBX 6045.08’s ave...
AstraZeneca serves up a double dose of good news
The drug giant AstraZeneca (LON:AZN) delivered a double dose of good news. It said the US regulator had granted a priority review for its new cancer treatment, and told investors a phase III trial of ...
AstraZeneca (AZN) Rating Reiterated by JPMorgan Chase & Co.
AstraZeneca (LON:AZN)‘s stock had its “buy” rating reaffirmed by equities research analysts at JPMorgan Chase & Co. in a research note issued on Friday. Several other brokerages have also commented on ...
AstraZeneca (AZN) PT Set at GBX 5,900 by UBS Group
AstraZeneca (LON:AZN) has been assigned a GBX 5,900 ($77.09) price objective by research analysts at UBS Group in a research note issued on Thursday, www.boersen-zeitung.de reports. The brokerage curr...